Skip to main content

Advertisement

SpringerLink
Log in

Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The prevalence of very severe obesity has increased progressively and faster than other classes of obesity over the last years. It is unclear whether the prevalence of obesity-related complications and health risks increases progressively or reaches a plateau above a certain degree of obesity. The aim of our study was to investigate whether the severity of obesity was correlated with the prevalence of type 2 diabetes mellitus (T2DM), impaired fasting glucose, impaired glucose tolerance (IGT), metabolic syndrome (MS), and cardiovascular diseases (CVDs) in a large cohort of patients with different degrees of obesity. A cross-sectional study was conducted in 938 obese patients without a previous diagnosis of diabetes. Patients were assigned to different categories of obesity: mild-moderate obesity (BMI 30–39.9 kg/m2), morbid obesity (BMI 40–49.9 kg/m2), and super-obesity (SO, BMI ≥50 kg/m2). The prevalence of IGF, IGT, screen-detected T2DM, MS, and CVD was higher in SO patients than in the other groups. Interestingly, the association between SO and either MS or CVD was independent of glucose tolerance status, indicating that factors other than glucose metabolism also favor cardio-metabolic complications in obese patients. In patients without screen-detected T2DM (n = 807), insulin sensitivity and secretion OGTT-derived indexes indicated that SO patients had the worst glucose homeostasis relative to the other categories of obesity, which was indicated by the most reduced disposition index in these patients, a predictor of future T2DM. In conclusion, SO patients have an extremely high prevalence of glucose metabolism deterioration, and cardio-metabolic complications are more prevalent in these patients compared to less obese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497

    Article  PubMed  Google Scholar 

  2. Micciolo R, Di Francesco V, Fantin F, Canal L, Harris TB et al (2010) Prevalence of overweight and obesity in Italy (2001–2008): is there a rising obesity epidemic? Ann Epidemiol 20:258–264

    Article  PubMed  Google Scholar 

  3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285: 2486–2497. http://www.ncbi.nlm.nih.gov/pubmed/11368702

    Google Scholar 

  4. Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89–95

    Article  PubMed  CAS  Google Scholar 

  5. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES et al (2010) Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 33:562–568

    Article  PubMed  Google Scholar 

  6. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE et al (2004) Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 27:2806–2812

    Article  PubMed  Google Scholar 

  7. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241

    Article  PubMed  CAS  Google Scholar 

  8. Sturm R (2007) Increases in morbid obesity in the USA: 2000–2005. Public Health 121:492–496

    Article  PubMed  CAS  Google Scholar 

  9. Dixon JB, O’Brien P (2001) A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord 25:793–797

    Article  PubMed  CAS  Google Scholar 

  10. Wolf AM, Buffington C, Beisiegel U (2006) Comparison of metabolic risk factors between severely and very severely obese patients. Obesity (Silver Spring) 14:2177–2183

    Article  Google Scholar 

  11. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2008) Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the national health and nutrition examination survey, 1999 to 2004. J Am Coll Surg 207:928–934

    Article  PubMed  Google Scholar 

  12. Baratta R, Amato S, Degano C, Farina MG, Patane G et al (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665–2671

    Article  PubMed  CAS  Google Scholar 

  13. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl 1):S62–S69. http://www.ncbi.nlm.nih.gov/pubmed/21193628

  14. Baratta R, Di Paola R, Spampinato D, Fini G, Marucci A et al (2003) Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms. J Mol Med (Berl) 81:718–723

    Article  CAS  Google Scholar 

  15. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D et al (2008) Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 57:3360–3364

    Article  PubMed  CAS  Google Scholar 

  16. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544–1548

    Article  PubMed  Google Scholar 

  17. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D et al (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27:96–106

    Article  PubMed  CAS  Google Scholar 

  18. O’Connell J, Kieran P, Gorman K, Ahern T, Cawood TJ et al (2010) BMI > or = 50 kg/m2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profiles. Public Health Nutr 13:1090–1098

    Article  PubMed  Google Scholar 

  19. Ferraro KF, Thorpe RJ Jr, Wilkinson JA (2003) The life course of severe obesity: does childhood overweight matter? J Gerontol B Psychol Sci Soc Sci 58:S110–S119

    Article  PubMed  Google Scholar 

  20. Monesi L, Baviera M, Marzona I, Avanzini F, Monesi G et al (2012) Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med 29(3):385–392. http://www.ncbi.nlm.nih.gov/pubmed/21913971

    Google Scholar 

  21. Muntoni S, Atzori L, Mereu R, Manca A, Satta G et al (2009) Prevalence of diagnosed and undiagnosed diabetes mellitus and impaired fasting glucose in Sardinia. Acta Diabetol 46:227–231

    Article  PubMed  CAS  Google Scholar 

  22. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J et al (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096

    Article  PubMed  Google Scholar 

  23. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198

    Article  PubMed  CAS  Google Scholar 

  24. Goodarzi MO, Cui J, Chen YD, Hsueh WA, Guo X et al (2011) Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. Am J Physiol Endocrinol Metab 301:E402–E408

    Article  PubMed  CAS  Google Scholar 

  25. Perotto M, Panero F, Gruden G, Fornengo P, Lorenzati B et al (2011) Obesity is associated with lower mortality risk in elderly diabetic subjects: the casale monferrato study. Acta Diabetol [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/22068621

  26. Drapeau V, Lemieux I, Richard D, Bergeron J, Tremblay A et al (2006) Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg 16:501–509

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Endocrinology Unit, Department of Clinical and Molecular Bio-Medicine, University of Catania Medical School, Garibaldi Hospital, Via Palermo 636, 95122, Catania, Italy

    Federica Vinciguerra, Roberto Baratta, Maria Grazia Farina, Patrizia Tita, Giuseppa Padova, Riccardo Vigneri & Lucia Frittitta

Authors
  1. Federica Vinciguerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Baratta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Grazia Farina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Tita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuseppa Padova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Riccardo Vigneri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lucia Frittitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Roberto Baratta or Lucia Frittitta.

Additional information

Communicated by Massimo Federici.

Federica Vinciguerra and Roberto Baratta equally contributed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vinciguerra, F., Baratta, R., Farina, M.G. et al. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease. Acta Diabetol 50, 443–449 (2013). https://doi.org/10.1007/s00592-013-0460-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-013-0460-3

Keywords

Search

Navigation